CA2220036A1 - Human neuropeptide receptor - Google Patents

Human neuropeptide receptor Download PDF

Info

Publication number
CA2220036A1
CA2220036A1 CA002220036A CA2220036A CA2220036A1 CA 2220036 A1 CA2220036 A1 CA 2220036A1 CA 002220036 A CA002220036 A CA 002220036A CA 2220036 A CA2220036 A CA 2220036A CA 2220036 A1 CA2220036 A1 CA 2220036A1
Authority
CA
Canada
Prior art keywords
polypeptide
receptor
polynucleotide
dna
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002220036A
Other languages
English (en)
French (fr)
Inventor
Daniel R. Soppet
Yi Li
Craig A. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/US1995/005616 priority Critical patent/WO1996034877A1/en
Priority to CA002220036A priority patent/CA2220036A1/en
Priority to EP95918991A priority patent/EP0828751A4/de
Publication of CA2220036A1 publication Critical patent/CA2220036A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA002220036A 1995-05-05 1995-05-05 Human neuropeptide receptor Abandoned CA2220036A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/US1995/005616 WO1996034877A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor
CA002220036A CA2220036A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor
EP95918991A EP0828751A4 (de) 1995-05-05 1995-05-05 Humaner neuropeptidrezeptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/005616 WO1996034877A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor
CA002220036A CA2220036A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor

Publications (1)

Publication Number Publication Date
CA2220036A1 true CA2220036A1 (en) 1996-11-07

Family

ID=25679790

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220036A Abandoned CA2220036A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor

Country Status (3)

Country Link
EP (1) EP0828751A4 (de)
CA (1) CA2220036A1 (de)
WO (1) WO1996034877A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410701B1 (en) 1995-05-05 2002-06-25 Human Genome Sciences, Inc. Human neuropeptide receptor
US20030022277A1 (en) * 1995-05-05 2003-01-30 Daniel R. Soppet Human neuropeptide receptor
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6001963A (en) * 1996-12-17 1999-12-14 Smithkline Beecham Corporation Ligands of the neuropeptide receptor HFGAN72
AU735760B2 (en) * 1997-04-24 2001-07-12 Merck Sharp & Dohme Limited Use of a NK-1 receptor antagonist and an SSRI for treating obesity
US5935814A (en) * 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) * 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
CA2233584A1 (en) * 1997-06-11 1998-12-11 Smithkline Beecham Corporation 7tm receptor hlwar77
US6166193A (en) * 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
WO1999030670A2 (en) * 1997-12-15 1999-06-24 Smithkline Beecham Plc Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
AUPP438598A0 (en) * 1998-06-29 1998-07-23 Garvan Institute Of Medical Research NPY-Y7 receptor gene
JP2002536425A (ja) * 1999-02-12 2002-10-29 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー オレキシン受容体アンタゴニストの新規用途
US6319710B1 (en) 1999-08-23 2001-11-20 Decode Genetics Ehf. Human narcolepsy gene
US6410712B1 (en) * 1999-10-25 2002-06-25 Decode Genetics Ehf. Human narcolepsy gene
ES2263647T3 (es) * 2000-08-25 2006-12-16 Phase One Pharma Oy Ltd. Metodo para reducir la sobreproduccion inducida por estres de neuropeptido y en un individuo.
BR0209334A (pt) 2001-05-05 2004-06-15 Smithkline Beecham Plc Aminas n-aroil cìclicas
US8093255B2 (en) 2008-10-09 2012-01-10 Glaxo Group Limited Imidazo[1,2-A]pyrimidines as orexin receptor antagonists
US8129384B2 (en) 2008-10-09 2012-03-06 Glaxo Group Limited Imidazo[1,2-a]pyrazines as orexin receptor antagonists
GB0823467D0 (en) 2008-12-23 2009-01-28 Glaxo Group Ltd Novel Compounds
EA201171293A1 (ru) 2009-04-24 2012-05-30 Глэксо Груп Лимитед 3-азабицикло[4.1.0]гептаны, применяемые в качестве антагонистов орексина
EP2470523A1 (de) 2009-08-24 2012-07-04 Glaxo Group Limited 5-methyl-piperidinderivate als orexinrezeptor-antagonisten zur behandlung von schlafstörungen
EP2470525A1 (de) 2009-08-24 2012-07-04 Glaxo Group Limited Piperidinderivate als orexinantagonisten
BR112013006594B1 (pt) 2010-09-22 2021-08-17 Eisai R&D Management Co., Ltd Composto ciclopropano antagonista de receptor da orexina e composição farmacêutica
WO2012089606A1 (en) 2010-12-28 2012-07-05 Glaxo Group Limited Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
WO2012089607A1 (en) 2010-12-28 2012-07-05 Glaxo Group Limited Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
KR102325655B1 (ko) 2014-08-06 2021-11-15 에자이 알앤드디 매니지먼트 가부시키가이샤 피리미딘-1-올 화합물의 제조 방법, 및 이의 중간체
MX2017004950A (es) 2014-10-23 2018-01-16 Eisai R&D Man Co Ltd Composiciones y metodos para tratar el insomnio.
BR112022002949A2 (pt) 2019-09-13 2022-06-07 Eisai R&D Man Co Ltd Composição farmacêutica para tratar insônia
BR112022012246A2 (pt) 2019-12-20 2022-08-30 Eisai R&D Man Co Ltd Uso de lemborexant para tratar insônia
TW202216705A (zh) 2020-07-17 2022-05-01 日商衛材R&D企管股份有限公司 取代哌啶化合物及其用途
TW202334120A (zh) 2022-01-14 2023-09-01 日商衛材R&D企管股份有限公司 經取代之哌啶化合物之結晶以及經取代之哌啶化合物之鹽及其等之結晶

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005302A1 (en) * 1994-08-11 1996-02-22 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof

Also Published As

Publication number Publication date
EP0828751A4 (de) 1999-01-20
EP0828751A1 (de) 1998-03-18
WO1996034877A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
CA2220036A1 (en) Human neuropeptide receptor
US20050214281A1 (en) G-protein coupled receptor
AU714642B2 (en) G-protein receptor HTNAD29
US20020106740A1 (en) Human G-protein receptor HPRAJ70
CA2242908A1 (en) Human g-protein chemokine receptor hsatu68
EP0955808A1 (de) Humaner, in g-protein gekoppelter rezeptor
US20080027020A1 (en) Human Neuropeptide Receptor
US6338951B1 (en) G-protein parathyroid hormone receptor HLTDG74
US5869632A (en) Human G-protein receptor HCEGH45
EP1146122A2 (de) Menschlicher G-protein chemokinrezeptor HDGNR10 (CCR5 Rezeptor)
CA2221637A1 (en) Human g-protein receptor hcegh45
US20020106741A1 (en) G protein receptor HTNAD29
AU715286B2 (en) Human neuropeptide receptor
AU763711B2 (en) Human neuropeptide receptor
CA2220978A1 (en) Human g-protein coupled receptor (hetgq23)
CA2224094A1 (en) Human amine receptor
US20020086362A1 (en) Human amine receptor
AU760468B2 (en) G-protein receptor HTNAD29
AU716415B2 (en) Pineal gland specific gene-1
US20030054487A1 (en) Human G-protein coupled receptor
US20020106734A1 (en) Adrenergic receptor
US20020146778A1 (en) Pineal gland specific gene-1
CA2221116A1 (en) G-protein parathyroid hormone receptor hltdg74
AU2003259580A1 (en) Human Neuropeptide Receptor
CA2242910A1 (en) Human g-protein coupled receptor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead